Crispr Therapeutics shares owned by Swiss National Bank
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Swiss National Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $7.4M | 158k | 46.98 |
| 2024-06-30 | $8.6M | 159k | 54.01 |
| 2024-03-31 | $10M | 149k | 68.16 |
| 2023-12-31 | $9.3M | 149k | 62.60 |
| 2023-09-30 | $7.5M | 165k | 45.39 |
| 2023-06-30 | $9.1M | 163k | 56.14 |
| 2023-03-31 | $7.3M | 161k | 45.23 |
| 2022-12-31 | $7.3M | 179k | 40.65 |
| 2022-09-30 | $11M | 175k | 65.35 |
| 2022-06-30 | $11M | 173k | 60.77 |
| 2022-03-31 | $9.1M | 145k | 62.77 |
| 2021-12-31 | $10M | 134k | 75.78 |
| 2021-09-30 | $15M | 134k | 111.93 |
| 2021-06-30 | $22M | 133k | 161.89 |
| 2021-03-31 | $17M | 135k | 121.85 |
| 2020-12-31 | $18M | 119k | 153.11 |
| 2020-09-30 | $9.7M | 116k | 83.64 |
| 2020-06-30 | $6.5M | 88k | 73.49 |
| 2020-03-31 | $2.5M | 58k | 42.42 |
| 2019-12-31 | $3.2M | 52k | 60.90 |
| 2019-09-30 | $2.0M | 50k | 40.99 |
| 2019-06-30 | $2.3M | 49k | 47.10 |
| 2019-03-31 | $1.3M | 38k | 35.71 |
| 2018-12-31 | $966k | 34k | 28.58 |
| 2018-09-30 | $1.5M | 34k | 44.35 |
| 2018-06-30 | $1.9M | 33k | 58.75 |